A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.
Where you live can make a difference in your cancer treatment. Local cancer patients benefit by having access to a large number of clinical trials. In fact, the Conquer Cancer Foundation of the American Society of Clinical Oncology recently honored Providence Oncology and Hematology Care Clinic at Providence Cancer Center for care that includes a large number of clinical trials offered to patients.
Battling breast cancer is about more than just fighting the disease. Sue Cook, manager of Providence Breast Services, and Toni Drew, a breast cancer survivor and volunteer with Providence Breast Cancer Outreach Program, share how a new approach is helping to heal the whole person.
In-between chemo treatments, this avid runner isn’t letting breast cancer slow her down. See how a local breast cancer patient laced up and got back to living life.
What do you do if you are at high risk of getting breast cancer? Besides monthly self-exams and regular mammograms, Alison Conlin, M.D., medical oncologist and medical director of Providence high-risk breast cancer services, explains what you need to know and do if you have a higher risk, including lifestyle changes.
A breast cancer diagnosis can be devastating, frightening, bewildering – it’s all of that when your world turns upside down. For many women, being able to talk with someone who’s been there before can be just what they need at this difficult time.
Stacy Lewis, M.D, and Christie J. Moore, D.O., have joined Providence Medical Group-Seaside. They will be caring for patients at the Providence Cancer Care Center Oncology and Hematology Care Clinic-Seaside every other Monday.
Debbie Clark is allergic to bees. And yet she credits a bee with saving her life.
Providence is the only cancer facility in Oregon to receive QOPI certification.
Bernie Fox, Ph.D., speaks at annual meeting in China about a new approach to determine immune response to tumors.